Should pregnant women be included in phase IV clinical drug trials?

Gerald G. Briggs; Janine E. Polifka; Katherine L. Wisner; Eric Gervais; Richard K. Miller; Anick Berard; Gideon Koren; Alicia Forinash; Craig V. Towers

doi:10.1016/j.ajog.2015.05.047

Should pregnant women be included in phase IV clinical drug trials?

Gerald G. Briggs
, Janine E. Polifka
, Katherine L. Wisner
, Eric Gervais
, Richard K. Miller
, Anick Berard
, Gideon Koren
, Alicia Forinash
, Craig V. Towers

Pharmacy Practice Department

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	810-815
Number of pages	6
Journal	American Journal of Obstetrics and Gynecology
Volume	213
Issue number	6
DOIs	https://doi.org/10.1016/j.ajog.2015.05.047
State	Published - 2015

ASJC Scopus Subject Areas

Obstetrics and Gynecology

Keywords

birth defects
developmental toxicity
drugs
phase IV clinical trials
pregnancy

Access to Document

10.1016/j.ajog.2015.05.047

Cite this

@article{6e947b9a101c4b1ca1c145e4e82739ff,

title = "Should pregnant women be included in phase IV clinical drug trials?",

keywords = "birth defects, developmental toxicity, drugs, phase IV clinical trials, pregnancy",

author = "Briggs, \{Gerald G.\} and Polifka, \{Janine E.\} and Wisner, \{Katherine L.\} and Eric Gervais and Miller, \{Richard K.\} and Anick Berard and Gideon Koren and Alicia Forinash and Towers, \{Craig V.\}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

doi = "10.1016/j.ajog.2015.05.047",

language = "English",

volume = "213",

pages = "810--815",

journal = "American Journal of Obstetrics and Gynecology",